|
|
|
|
|
| For the past decade, baby boomers have been well-educated about the severity of blood clots in the brain causing strokes. But what many of them still do not understand is the potentially fatal effects of blood clots in their legs and arms as well as their available treatment options. An innovative clot-removal procedure, highlighted in a recent study, yields a 94.7 percent success rate in preventing amputation. |
|
|
| SyncTool software helps to predict which heart failure patients will benefit from cardiac resynchronization therapy (CRT). Syntermed also unveils ReconTools™ at the American Society of Nuclear Cardiology, Sept. 10-14, Boston, MA. Emory University announced it is exclusively licensing Emory Reconstruction Toolbox (ERTb) to Syntermed and the company will market ERTb software as ReconTools™. ReconTools provide reconstructed data sets that can be analyzed by many quantitative platforms including Emory Cardiac Toolbox™ (ECTb), providing an integrated, complete software... |
|
|
| Syntermed, Inc., an Atlanta-based nuclear medicine imaging and informatics software company will demonstrate several new cardiac imaging software programs at the American Society of Nuclear Cardiologists, meeting in Boston through Sunday. Syntermed Live is one of the featured products along with Emory Cardiac Toolbox, SyncTool and ReconTool. ..."Nuclear cardiologists are utilizing the Syntermed Live™ system to easily access secure, high-resolution heart images and diagnostic information. The trend towards virtual access and remote reading is more than a convenience for nuclear... |
|
|
| In an innovative use of social networking site Twitter, Indian heart surgeon Dr. Mani Sivasubramanian is raising awareness and funds for children born with congenital heart defects -- by doing a 24 hour non-stop day-and-night Tweet-a-thon on September 12th, 2008. |
|
|
| Blood pressure readings jump around so much that you are more likely to get an accurate reading if you check it at home rather than in the doctor's office, reports the September 2008 issue of the Harvard Heart Letter. |
|
|
| Professional Postgraduate Services® (PPS) proudly announces the launch of Recognizing and Managing Diseases of the Leg: a Self-Study Program, a dynamic, web-based, continuing medical education (CME)-certified learning intervention. These activities are featured on LegDisorders.org, the official website of the PPS-sponsored Biology of Leg Disorders (BOLD®) educational initiative. |
|
|
| CoreValve ( www.corevalve.com ) announced today that five (5) clinical evaluation sites—two in New Zealand and three in Australia—have now completed their first series of proctored cases using the Company’s proprietary ReValving® System for percutaneous aortic valve replacement (PAVR), which features a porcine pericardium valve mounted in a self-expanding frame. |
|
|
| ev3’s former Vice President of International Clinical Affairs will oversee clinical development of Stentys’ stent for treatment of blocked coronary artery bifurcations “Dr. Spaargaren’s extensive experience in leading the clinical development of cardiovascular technologies while working for companies such as ev3, Boston Scientific and Medtronic will certainly fortify our ongoing clinical development efforts.” Gonzague Issenmann, Co-Founder and CEO, Stentys |
|
|
| The September 2008 issue of EMS Magazine includes a detailed look at experiences and issues surrounding prehospital use of therapeutic hypothermia in treating cardiac patients; the feature is authored by global leaders in the field, soon to lead international discussion on the matter. |
|
|
| Northwest EMC, Inc., an industry leading EMC and EMI Test and certification service provider, is expanding its operations into the Minneapolis, Minnesota area. After years of serving the west coast with EMC facilities in Washington, Oregon and California, a strong growth curve has helped the EMC market leader to expand and serve other geographies. |
|
|
